Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib versus dacarbazine for metastatic uveal melanoma
ISRCTN75033520Phase 2Terminated
- Sponsor
- Clatterbridge Cancer Centre
- Start
- Oct 2010
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, open-label trial of sunitinib and dacarbazine in intraocular melanoma, sponsored by Clatterbridge Cancer Centre. Primary endpoint: Progression-free survival. Started Oct 2010; status: terminated.
02
Drugs
sunitinibdacarbazine
03
Conditions
intraocular melanoma
Beyond the preview
Go deeper on ISRCTN75033520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN75033520.